News in English
Browse the latest English-language press releases. Access breaking news spanning a variety of topics and industries. Stay updated on important announcements and developments, all delivered in English.
Feb 27, 2026 at 8:51 PM
The Cannabist Company Further Extends Forbearance Agreement With Senior Noteholders
CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers, and retailers of cannabis products in the United States, today announced that the ad hoc group of noteholders of the Company’s 9.25% Senior Secured Notes due December 31, 2028 and the 9.00% Senior Secured Convertible Notes due December 31, 2028 (collectively, the “Notes”), which are parties to t...
Feb 27, 2026 at 8:31 PM
KIRIN HYOKETSU Expands into U.S. RTD Market with Local Production
TOKYO--(BUSINESS WIRE)--New Belgium Brewing, the Kirin Group company leading its U.S. alcoholic beverage business, will launch two original flavors - KIRIN HYOKETSU STRAWBERRY and KIRIN HYOKETSU PINEAPPLE – under the KIRIN HYOKETSU (HYOKETSU) brand, manufactured and sold by Kirin Brewery Company, Limited (Kirin Brewery). The ready to drink cocktail will be available in Hawaii, Tampa, FL, and The Japan Pavilion at EPCOT theme park, operated by Mitsukoshi (U.S.A.), on March 2. Created with Americ...
Feb 27, 2026 at 8:00 PM
CWH INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Camping World Holdings, Inc.
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Camping World Holdings, Inc. (“Camping World” or the “Company”) (NYSE:CWH) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On October 28, 2025, Camping World issued a press release announcing its third-quarter 2025 financial...
Feb 27, 2026 at 8:00 PM
REMINDER: Coreweave, Inc. Investors With Significant Losses Must Act By March 13, 2026
NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds Coreweave, Inc. (“Coreweave” or the “Company”) (NASDAQ:CRWV) investors of the March 13, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead...
Feb 27, 2026 at 8:00 PM
EPAM SYSTEMS, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against EPAM Systems, Inc. (“EPAM” or the “Company”) (NYSE:EPAM). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On February 19, 2026, EPAM reported its financial results for fourth quarter and full year 2025. On an ear...
Feb 27, 2026 at 7:00 PM
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034
BEIJING, China--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner IDEAYA Biosciences, Inc. (“IDEAYA”; Nasdaq: IDYA) has dosed the first patient in IDEAYA’s Phase 1 dose-escalation/expansion clinical trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC. Pursuant to th...
Feb 27, 2026 at 7:00 PM
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034
BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner IDEAYA Biosciences, Inc. (“IDEAYA”; Nasdaq: IDYA) has dosed the first patient in IDEAYA’s Phase 1 dose-escalation/expansion clinical trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC. Pursuant to the compa...
Feb 27, 2026 at 6:45 PM
Secretary of War Pete Hegseth Visits L3Harris Solid Rocket Motor Site
CAMDEN, Ark.--(BUSINESS WIRE)--Secretary of War Pete Hegseth visited the L3Harris Technologies (NYSE: LHX) Camden site today as part of his nationwide “Arsenal of Freedom” tour, highlighting the importance of American manufacturing capacity in strengthening the defense industrial base and supporting U.S. and allied warfighters. Secretary Hegseth toured several of the site’s solid rocket motor production facilities and spoke with the 1,500 employees who design, build and deliver propulsion syste...
Feb 27, 2026 at 6:01 PM
National Condom Month: Why Today’s Protection Is About Pleasure, Confidence and Connection, According to Sex & Relationship Expert, Dr. Deb Laino
PHILADELPHIA--(BUSINESS WIRE)--In recognition of National Condom Month, sex and relationship therapist Dr. Deb Laino is encouraging young adults to prioritize safer sex practices - not just for protection, but for the emotional and relational benefits that come with feeling secure and aligned with your partner. As conversations around consent and sexual wellness continue to evolve, Dr. Laino emphasizes that condoms are not just about prevention - they help create a shared understanding of respo...
Feb 27, 2026 at 6:00 PM
The Baldwin Group Announces Future Leadership Transition in its Underwriting, Capacity, and Technology Solutions Segment
TAMPA, Fla.--(BUSINESS WIRE)--The Baldwin Group (“Baldwin” or the “Company”) (NASDAQ: BWIN), a leading independent insurance brokerage and advisory firm delivering tailored insurance solutions to a wide range of personal and commercial clients, today announced a long-planned leadership transition within its Underwriting, Capacity, & Technology Solutions (“UCTS”) operating group, effective January 1, 2027. Amy Carlisle will become Chief Executive Officer of UCTS, succeeding Jim Roche, who wi...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.